These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 11747904)

  • 41. Characterization of a novel endocannabinoid, virodhamine, with antagonist activity at the CB1 receptor.
    Porter AC; Sauer JM; Knierman MD; Becker GW; Berna MJ; Bao J; Nomikos GG; Carter P; Bymaster FP; Leese AB; Felder CC
    J Pharmacol Exp Ther; 2002 Jun; 301(3):1020-4. PubMed ID: 12023533
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Oxygenated metabolites of anandamide and 2-arachidonoylglycerol: conformational analysis and interaction with cannabinoid receptors, membrane transporter, and fatty acid amide hydrolase.
    van der Stelt M; van Kuik JA; Bari M; van Zadelhoff G; Leeflang BR; Veldink GA; Finazzi-Agrò A; Vliegenthart JF; Maccarrone M
    J Med Chem; 2002 Aug; 45(17):3709-20. PubMed ID: 12166944
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cannabidiol lacks the vanilloid VR1-mediated vasorespiratory effects of capsaicin and anandamide in anaesthetised rats.
    McQueen DS; Bond SM; Smith PJ; Balali-Mood K; Smart D
    Eur J Pharmacol; 2004 May; 491(2-3):181-9. PubMed ID: 15140635
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effect of anandamide on nonadrenergic noncholinergic-mediated relaxation of rat corpus cavernosum.
    Ghasemi M; Sadeghipour H; Mani AR; Tavakoli S; Hajrasouliha AR; Ebrahimi F; Dehpour AR
    Eur J Pharmacol; 2006 Aug; 544(1-3):138-45. PubMed ID: 16824514
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Inflammatory mediators convert anandamide into a potent activator of the vanilloid type 1 transient receptor potential receptor in nociceptive primary sensory neurons.
    Singh Tahim A; Sántha P; Nagy I
    Neuroscience; 2005; 136(2):539-48. PubMed ID: 16198486
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Potentiation of the action of anandamide on hippocampal slices by the fatty acid amide hydrolase inhibitor, palmitylsulphonyl fluoride (AM 374).
    Gifford AN; Bruneus M; Lin S; Goutopoulos A; Makriyannis A; Volkow ND; Gatley SJ
    Eur J Pharmacol; 1999 Oct; 383(1):9-14. PubMed ID: 10556675
    [TBL] [Abstract][Full Text] [Related]  

  • 47. N-acyl-dopamines: novel synthetic CB(1) cannabinoid-receptor ligands and inhibitors of anandamide inactivation with cannabimimetic activity in vitro and in vivo.
    Bisogno T; Melck D; Bobrov MYu ; Gretskaya NM; Bezuglov VV; De Petrocellis L; Di Marzo V
    Biochem J; 2000 Nov; 351 Pt 3(Pt 3):817-24. PubMed ID: 11042139
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Neurobehavioral activity in mice of N-vanillyl-arachidonyl-amide.
    Di Marzo V; Breivogel C; Bisogno T; Melck D; Patrick G; Tao Q; Szallasi A; Razdan RK; Martin BR
    Eur J Pharmacol; 2000 Oct; 406(3):363-74. PubMed ID: 11040343
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Temperature-dependent activation of recombinant rat vanilloid VR1 receptors expressed in HEK293 cells by capsaicin and anandamide.
    Sprague J; Harrison C; Rowbotham DJ; Smart D; Lambert DG
    Eur J Pharmacol; 2001 Jul; 423(2-3):121-5. PubMed ID: 11448475
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Neonatal anandamide treatment results in prolonged mitochondrial damage in the vanilloid receptor type 1-immunoreactive B-type neurons of the rat trigeminal ganglion.
    Szoke E; Czéh G; Szolcsányi J; Seress L
    Neuroscience; 2002; 115(3):805-14. PubMed ID: 12435419
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pharmacological characterisation of cannabinoid CB(1) receptors in the rat and mouse.
    Lay L; Angus JA; Wright CE
    Eur J Pharmacol; 2000 Mar; 391(1-2):151-61. PubMed ID: 10720647
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The anandamide transport inhibitor AM404 reduces ethanol self-administration.
    Cippitelli A; Bilbao A; Gorriti MA; Navarro M; Massi M; Piomelli D; Ciccocioppo R; Rodríguez de Fonseca F
    Eur J Neurosci; 2007 Jul; 26(2):476-86. PubMed ID: 17650118
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Biosynthesis and degradation of anandamide and 2-arachidonoylglycerol and their possible physiological significance.
    Sugiura T; Kobayashi Y; Oka S; Waku K
    Prostaglandins Leukot Essent Fatty Acids; 2002; 66(2-3):173-92. PubMed ID: 12052034
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Suppression of nerve growth factor Trk receptors and prolactin receptors by endocannabinoids leads to inhibition of human breast and prostate cancer cell proliferation.
    Melck D; De Petrocellis L; Orlando P; Bisogno T; Laezza C; Bifulco M; Di Marzo V
    Endocrinology; 2000 Jan; 141(1):118-26. PubMed ID: 10614630
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Activation of capsaicin-sensitive primary sensory neurones induces anandamide production and release.
    Ahluwalia J; Yaqoob M; Urban L; Bevan S; Nagy I
    J Neurochem; 2003 Feb; 84(3):585-91. PubMed ID: 12558978
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Palmitoylethanolamide enhances anandamide stimulation of human vanilloid VR1 receptors.
    De Petrocellis L; Davis JB; Di Marzo V
    FEBS Lett; 2001 Oct; 506(3):253-6. PubMed ID: 11602256
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Assessment of anandamide interaction with the cannabinoid brain receptor: SR 141716A antagonism studies in mice and autoradiographic analysis of receptor binding in rat brain.
    Adams IB; Compton DR; Martin BR
    J Pharmacol Exp Ther; 1998 Mar; 284(3):1209-17. PubMed ID: 9495885
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Microinjection of 2-arachidonoyl glycerol into the rat ventral hippocampus differentially modulates contextually induced fear, depending on a persistent pain state.
    Rea K; Ford GK; Olango WM; Harhen B; Roche M; Finn DP
    Eur J Neurosci; 2014 Feb; 39(3):435-43. PubMed ID: 24494683
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Activation of vanilloid receptor type I in the endoplasmic reticulum fails to activate store-operated Ca2+ entry.
    Wisnoskey BJ; Sinkins WG; Schilling WP
    Biochem J; 2003 Jun; 372(Pt 2):517-28. PubMed ID: 12608892
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Overlap between the ligand recognition properties of the anandamide transporter and the VR1 vanilloid receptor: inhibitors of anandamide uptake with negligible capsaicin-like activity.
    De Petrocellis L; Bisogno T; Davis JB; Pertwee RG; Di Marzo V
    FEBS Lett; 2000 Oct; 483(1):52-6. PubMed ID: 11033355
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.